11:46:43 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-14 Bokslutskommuniké 2024
2024-11-14 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-30 Årsstämma 2024
2024-05-17 Kvartalsrapport 2024-Q1
2024-03-01 Ordinarie utdelning CSMED 0.00 DKK
2024-02-14 Bokslutskommuniké 2023
2023-12-15 Ordinarie utdelning CSMED 0.00 DKK
2023-07-18 Kvartalsrapport 2023-Q3
2023-05-17 Kvartalsrapport 2023-Q2
2023-04-14 Extra Bolagsstämma 2023
2023-02-17 Kvartalsrapport 2023-Q1
2023-02-14 Årsstämma 2023
2023-02-10 Ordinarie utdelning CSMED 0.00 DKK
2022-11-18 Bokslutskommuniké 2022
2022-08-13 Kvartalsrapport 2022-Q3
2022-05-20 Kvartalsrapport 2022-Q2
2022-02-18 Kvartalsrapport 2022-Q1
2021-12-10 Ordinarie utdelning CSMED 0.00 DKK
2021-12-09 Årsstämma 2022
2021-11-18 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2022-08-24 08:00:00

CS MEDICA's ("CS Medica") incentive program with Diaz Capital Invest AB is now vested with the first portion of the warrants in series TO2 being exercised with 255,300 shares at the strike price of 10.30 DKK per share. The remaing TO3 series warrants, 250,000 shares, can be exercised at a strike price of 31.50 DKK per share if they vest.

CS MEDICA currently operates with 3 series of warrants, TO1, TO2 and TO3, in addition to the incentive warrants issued to the management and employees in CS MEDICA:
  • The TO1 warrants have been submitted to all subscribers of shares in CS Medica's IPO in September 2021. The TO1 warrants can be exercised up until 1st of September 2022. The exercise price is DKK 9,30. If all the TO1 warrants are exercised the Company will receive approx. DKK 10.8 million before deduction of transaction related costs.

  • The TO2 and the TO3 warrants have been issued to CS MEDICA's investor relation service partner Diaz Capital Invest AB and persons/companies related to Capital Invest AB as consideration for the investor relation services performed by Diaz Capital Invest AB to CS MEDICA. The proceeds from the exercise of the warrants will be used to accelerate the growth in CS MEDICA.

  • On 16. August 2022, Diaz Capital Invest AB and persons/companies related to Capital Invest AB have exercised 255,300 out of 350,000 TO2 warrants at an exercise price of DKK 10.30 per share, which will result in DKK 2,629,590 being contributed to CS MEDICA in the near future. No additional TO2 warrants can be exercised.

  • 250,000 TO3 warrants can be exercised during the period 21 August 2023 - 4 September 2023 (both days inclusive) at an exercise price of 31.50 per share provided that certain KPI's are met. If all the TO3 warrants are exercised an amount of DKK 7,875,000 will be contributed to CS MEDICA.

The TO3 series warrants are the last warrants in the series approved for exercise in CS MEDICA, which is also the serie used in the valuation of CS MEDICA when seeking new capital to accelerate the growth in CS MEDICA.

The complete terms of the warrants and subscription hereof can be found in a schedule to CS MEDICA's articles of association which are available at CS MEDICA's homepage.  After the exercise of the TO2 series warrants, the registration of the share issue, will be performed at the Danish Companies Registration Office with the total number of shares being raised from 11.002.000 with a share capital of DKK 715.130, to 11.257.300 shares with a share capital of 731.725 DKK.